Skip to main content
Bonesupport Holding logo

Bonesupport Holding — Investor Relations & Filings

Ticker · BONEX ISIN · SE0009858152 LEI · 549300COLY053IGTLD63 ST Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2018-06-29 Declaration of Voting R…
Country SE Sweden
Listing ST BONEX

About Bonesupport Holding

https://www.bonesupport.com/en-eu/

Bonesupport Holding is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes. Its core product platform, CERAMENT®, is an innovative range of osteoconductive and drug-eluting products designed to heal bone defects. A key characteristic of CERAMENT® is its ability to remodel into the patient's own host bone, typically within six to twelve months. The products are used to treat bone voids and defects arising from trauma, infection, disease, or related surgical procedures. The radiopaque nature of the material allows for visualization during and after surgery.

Recent filings

Filing Released Lang Actions
Ändring av antalet aktier och röster i BONESUPPORT HOLDING AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement dated June 29, 2018, detailing an increase in the total number of shares and votes due to the exercise of warrants ('utnyttjande av teckningsoptioner'). It explicitly states that this information is required to be made public under the EU Market Abuse Regulation ('EU:s marknadsmissbruksförordning'). This type of announcement, which reports a change in the total share count, falls under the category of changes to the capital structure or share issuance. The most fitting category is 'Share Issue/Capital Change' (SHA), as the increase is directly caused by the exercise of options, leading to new shares being issued. It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a financing update (CAP) which usually implies fundraising activities rather than the mechanical result of options being exercised.
2018-06-29 Swedish
BONESUPPORT provides update on US orders of CERAMENT BVF
Regulatory Filings Classification · 1% confidence The document is explicitly titled "Press Release" and provides an update on US orders for a specific product (CERAMENT BVF) following a previous announcement regarding distribution agreements. It discusses operational changes, sales figures, and future plans, which is characteristic of a general corporate announcement or news release. Since it is not a formal regulatory filing like a 10-K, an Earnings Release (ER) which focuses on period results, or a specific legal/governance document, the most appropriate classification is the general regulatory announcement fallback category, RNS, as it is a public disclosure mandated by regulations (EU Market Abuse Regulation mentioned at the end). Given its short length and nature as an update rather than a comprehensive report, RNS is the best fit over other specific report types.
2018-06-21 English
BONESUPPORT lämnar uppdatering om orderläget för CERAMENT BVF i USA
Regulatory Filings Classification · 1% confidence The document is explicitly titled "Press Release" and contains an update regarding the order status for a specific product (CERAMENT BVF) in the USA following the termination of a distribution agreement. It discusses business strategy, future distribution plans, and provides financial context (historical sales growth). This type of immediate, material business update, released via a press release format, typically falls under general regulatory announcements or earnings/business updates. Since it is not a full financial report (10-K, IR), a formal earnings release (ER) focusing only on key figures, or a transcript (CT), the most appropriate classification is a general Regulatory Filing (RNS), as it is a mandatory disclosure under EU market abuse regulation ('EU:s marknadsmissbruksförordning'). It is not a specific announcement like a dividend (DIV) or management change (MANG).
2018-06-21 Swedish
BONESUPPORT to significantly expand its European sales organization
Report Publication Announcement Classification · 1% confidence The document is a press release dated May 29, 2018, announcing BONESUPPORT's plan to expand its European sales organization and highlighting the strong sales momentum and clinical data for its CERAMENT products. It discusses business strategy, sales growth figures (SEK 62M to SEK 129M), and future market penetration plans. This content is characteristic of an announcement related to business operations, strategy, and financial performance updates that are not a full annual report (10-K) or a formal earnings release (ER) focusing only on period results. Since it details strategic business expansion and commercial updates, it fits best under the general category of corporate updates or investor relations material. Given the options, it is not a formal regulatory filing like 10-K, AR, or IR. It is not a transcript (CT), dividend notice (DIV), or management discussion (MDA) in the formal sense. It is an announcement of business activity and growth strategy, which often falls under general investor communications. Since it is a press release detailing operational expansion and commercial success, and does not fit the specific definitions of CAP, ER, or IR, it is best classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standard announcements, or potentially an Investor Presentation (IP) if it were structured as slides, but as a press release, RNS is the most appropriate fallback for significant, non-standard corporate news.
2018-05-29 English
BONESUPPORT expanderar sin säljorganisation i Europa
Regulatory Filings Classification · 1% confidence The document is a press release from BONESUPPORT announcing an expansion of its European sales force and referencing recent study presentations. It contains company updates, financial growth figures (sales from 62 MSEK to 129 MSEK between 2015 and 2017), and contact information for IR/CFO. Crucially, the final paragraph states: "Denna information är sådan information som BONESUPPORT HOLDING AB (publ) är skyldigt att offentliggöra enligt lagen om värdepappersmarknaden. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 29 maj 2018 kl. 08.00 CET." This structure strongly suggests a mandatory regulatory disclosure, but it is not a full financial report (10-K, IR) or a specific results announcement (ER). Since it is a general, material announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory filing fallback category, RNS (Regulatory Filings). The document length is short (under 4,000 characters), which supports it being an announcement rather than a full report.
2018-05-29 Swedish
BONESUPPORT tecknar strategiskt avtal med Collagen Matrix Inc. för att utöka produktutbudet i USA
Regulatory Filings Classification · 1% confidence The document is a press release dated May 24, 2018, announcing a strategic agreement between BONESUPPORT and Collagen Matrix Inc. to expand product offerings in the USA. It details business strategy, product integration, and future commercial plans. The text concludes with a statement that the information is required to be made public according to securities market law ('lagen om värdepappersmarknaden') and was released at a specific time. This structure strongly suggests a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, IR, ER) or corporate action categories (like DIV, SHA, CAP). Since it is a formal announcement of a significant business development required for public disclosure, and it doesn't fit other specific categories, the most appropriate fallback is Regulatory Filings (RNS). The document length (4645 chars) is substantial enough to be the primary announcement, not just a notice of publication (RPA).
2018-05-24 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.